Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM further positions the company as a global leader in diagnostic imaging in radiology and cardiology. The merger allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents. The synergies among both companies' product portfolios, complementary customer bases and technical expertise will strengthen Bracco Diagnostics' position in the evolving field of imaging informatics and patient management.
If you enjoy this content, please share it with a colleague
Related Content
May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the ...
May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...
May 15, 2024 — Transfer learning (TL) models trained on heterogeneous public datasets and fine-tuned using institutional ...
May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...
May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...
May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...
May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...
May 7, 2024 — The Radiological Society of North America (RSNA) and the Radiological and Diagnostic Imaging Society of ...
May 7, 2024 — The Magna Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting showed a ...
May 7, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and ...